Asthma And COPD Drugs Key Players and their Developments
The global asthma and COPD drugs market size was calculated at USD 41.04 billion in 2024, to reach USD 43.1 billion in 2025 is expected to be worth USD 66.92 billion by 2034, expanding at a CAGR of 5.01% from 2024 to 2034.
Asthma And COPD Market Top Companies
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd
- Merck & Co. Inc
- Grifols S.A.
- Novartis AG
- Cipla Inc.
- Abbott
- Astellas Pharma
- Hoffmann-La Roche Ltd
- Glenmark Pharmaceuticals
